• Disease areas
  • Science & technology
  • Partnering
  • Sustainable business
  • Careers
  • About us
  • Our products
  • Patients
  • Investors
  • News & media
  • Healthcare professionals
  • Contact us

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Visit Capital Markets day Stock information Press releases and company announcements R&D Pipeline Upcoming events

Annual Report

Cover page of the Novo Nordisk Annual Report 2024 - Novo Nordisk employees Steve Piaget and Marie Ange Gahozo from our site in Kalundborg, Denmark, overseeing an active construction project

Annual Report 2024

Download Annual Report

Latest news

{{'2025-05-16T11:02:00Z' | dateFormatFilter}}

Novo Nordisk A/S: Lars Fruergaard Jørgensen to step down as CEO of Novo Nordisk

Read more

{{'2025-05-14T10:59:39Z' | dateFormatFilter}}

Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases

Read more

{{'2025-05-12T06:01:36Z' | dateFormatFilter}}

Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE

Read more

News archive

Career Opportunities

Dear colleague

Please click here to go directly to our internal career site to view all our current job openings.

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.

 

 

 

NOVO NORDISK HQ

Novo Nordisk A/S
Novo Alle 1
2880 Bagsværd
Denmark
+45-4444-8888
CVR-no. 24256790

 

Our medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page

Helpful links

Report a side effect Patient help Supplier help Product list Contact us Annual Report ESG reporting Novo Nordisk Foundation

Follow us

Social media community guidelines LinkedIn YouTube Facebook X (Twitter) Instagram TikTok

Find your local office

Select location
© 2025 Novo Nordisk A/S
Data Privacy
Cookie policy
Cookie settings

change